Table 2.
Summary of types of first event, as reported for the 974 ‘registration cohort’ patients in whom an EFS was reported.
| Type of event | N | % |
|---|---|---|
| New metastases | 521 | 53 |
| Combination of events | 144 | 15 |
| New metastases/progression of existing metastases | 58 | 40 |
| Local recurrence/new metastases | 52 | 36 |
| Local recurrence/new metastases/progression of existing metastases | 13 | 9 |
| Other or unknown combination | 21 | 15 |
| Progression of existing metastatic disease | 89 | 9 |
| Local progression | 74 | 8 |
| Local recurrence | 70 | 7 |
| Death without any previously reported progression | 41 | 4 |
| Cause of death attributed to osteosarcoma/treatmenta | 32 | 78 |
| Other cause of death | 9 | 22 |
| Secondary malignancy | 26 | 3 |
| Unknown event type | 9 | 1 |
| Total | 974 | 100 |
Or implicitly attributed to osteosarcoma/treatment as death occurred during therapy.